scholarly journals Non-Invasive Measurement of Brachial-Ankle Pulse Wave Velocity Is Associated with Serum C-Reactive Protein but Not with .ALPHA.-Tocopherol in Japanese Middle-Aged Male Workers

2004 ◽  
Vol 27 (3) ◽  
pp. 173-180 ◽  
Author(s):  
Tomonori OKAMURA ◽  
Yuri MORIYAMA ◽  
Takashi KADOWAKI ◽  
Hideyuki KANDA ◽  
Hirotsugu UESHIMA
Keyword(s):  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Alpha Tocopherol ◽  
C Reactive Protein ◽  
Middle Aged ◽  
Reactive Protein ◽  
Non Invasive ◽  
Invasive Measurement ◽  
Middle Aged Male

scholarly journals Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity

Hypertension ◽  
2009 ◽  
Vol 53 (2) ◽  
pp. 150-157 ◽  
Author(s):  
Wiebke Schumacher ◽  
John Cockcroft ◽  
Nicholas J. Timpson ◽  
Carmel M. McEniery ◽  
John Gallacher ◽  
...  
Keyword(s):  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Aortic Pulse Wave Velocity ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Circulating Levels ◽  
Protein Genotype

NON-INVASIVE MEASUREMENT OF HEART-FEMORAL PULSE WAVE VELOCITY

2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e224
Author(s):  
C. Magistri ◽  
F.U.S. Mattace Raso ◽  
F. Battista ◽  
F. Anastasio ◽  
G. Pucci
Keyword(s):  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Non Invasive ◽  
Invasive Measurement

The association between cumulative C-reactive protein and brachial–ankle pulse wave velocity

2019 ◽  
Vol 32 (5) ◽  
pp. 789-796 ◽  
Author(s):  
Lixia Sun ◽  
Chunhong Ning ◽  
Jiqiang Liu ◽  
Tao Yao ◽  
Li Zhang ◽  
...  
Keyword(s):  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
C Reactive Protein ◽  
Reactive Protein

Limitations and pitfalls of non-invasive measurement of arterial pressure wave reflections and pulse wave velocity

2009 ◽  
Vol 3 (2) ◽  
pp. 79 ◽  
Author(s):  
Patrick Segers ◽  
Jan Kips ◽  
Bram Trachet ◽  
Abigail Swillens ◽  
Sebastian Vermeersch ◽  
...  
Keyword(s):  
Arterial Pressure ◽  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pressure Wave ◽  
Pulse Wave ◽  
Wave Reflections ◽  
Non Invasive ◽  
Invasive Measurement

scholarly journals Central arterial stiffness is associated with systemic inflammation among Asians with type 2 diabetes

2016 ◽  
Vol 13 (4) ◽  
pp. 303-306 ◽  
Author(s):  
Xiao Zhang ◽  
Jian Jun Liu ◽  
Chee Fang Sum ◽  
Yeoh Lee Ying ◽  
Subramaniam Tavintharan ◽  
...  
Keyword(s):  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Augmentation Index ◽  
High Sensitivity ◽  
Soluble Receptor ◽  
C Reactive Protein ◽  
Advanced Glycation ◽  
Reactive Protein ◽  
Glycation End Products

Objective: To examine the relationship between inflammation and central arterial stiffness in a type 2 diabetes Asian cohort. Method: Central arterial stiffness was estimated by carotid-femoral pulse wave velocity and augmentation index. Linear regression model was used to evaluate the association of high-sensitivity C-reactive protein and soluble receptor for advanced glycation end products with pulse wave velocity and augmentation index. High-sensitivity C-reactive protein was analysed as a continuous variable and categories (<1, 1–3, and >3 mg/L). Results: There is no association between high-sensitivity C-reactive protein and pulse wave velocity. Augmentation index increased with high-sensitivity C-reactive protein as a continuous variable ( β = 0.328, p = 0.049) and categories ( β = 1.474, p = 0.008 for high-sensitivity C-reactive protein: 1–3 mg/L and β = 1.323, p = 0.019 for high-sensitivity C-reactive protein: >3 mg/L) after multivariable adjustment. No association was observed between augmentation index and soluble receptor for advanced glycation end products. Each unit increase in natural log–transformed soluble receptor for advanced glycation end products was associated with 0.328 m/s decrease in pulse wave velocity after multivariable adjustment ( p = 0.007). Conclusion: Elevated high-sensitivity C-reactive protein and decreased soluble receptor for advanced glycation end products are associated with augmentation index and pulse wave velocity, respectively, suggesting the potential role of systemic inflammation in the pathogenesis of central arterial stiffness in type 2 diabetes.

scholarly journals Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs

2019 ◽  
pp. 70-79 ◽  
Author(s):  
S. V. Nedogoda ◽  
E. V. Chumachek ◽  
V. V. Tsoma ◽  
A. S. Salasyuk ◽  
V. O. Smirnova ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Augmentation Index ◽  
Model Assessment ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Previous Therapy ◽  
Azilsartan Medoxomil

Aim. To assess the possibility of azilsartan medoxomil to achieve target blood pressure (BP) (less than 130/80 mm Hg), to study angioprotective features and reduction of adipokines levels and inflammatory markers in patients with hypertension and previous therapy with other ARBs.Material and methods. In open observational study with 24 weeks follow-up were included 60 patients with previous therapy (losartan or valsartan or telmisartan).All patients underwent ambulatory BP monitoring, applanation tonometry (determination of the augmentation index and central BP), measurement of the pulse wave velocity, laboratory tests (lipid profile, uric acid, fasting glucose, Homeostasis Model Assessment, homocysteine, leptin, adiponectin, highly sensitive C-reactive protein, tumor necrosis factor alpha, interleukin-6).Results. Azilsartan provided the systolic BP (29,05%, 22,5% and 8,9%) and diastolic BP reduction 18,82%, 20,46% and 8,54% (p<0,05) in patients previously treated with losartan, valsartan or telmisartan, respectively. Central systolic BP (by 25,95%, 8,78%, 11,94%), central pulse BP (by 40%, 18,38% and 19,6%), augmentation index (by 28,87%, 20,69% and 14,29%) and pulse wave velocity (by 21,57%, 24,56% and 24,92%) were decreased (p<0,05). There were positive changes in leptin, C-reactive protein, IL-6, adiponectin levels in all patients with losartan, valsartan or telmisartan initial therapy (p<0,05).Conclusion. Azilsartan medoxomil has advantages in BP control, the arterial elasticity improving, reducing of insulin-resistance and inflammation.

NON-INVASIVE MEASUREMENT OF AORTIC PULSE WAVE VELOCITY

2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e199
Author(s):  
A. Grillo ◽  
F. Moretti ◽  
M. Rovina ◽  
C. Baldi ◽  
L. Salvi ◽  
...  
Keyword(s):  
Pulse Wave Velocity ◽  
Wave Velocity ◽  
Pulse Wave ◽  
Aortic Pulse Wave Velocity ◽  
Non Invasive ◽  
Invasive Measurement
Sign in / Sign up

Export Citation Format

Share Document